BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16182129)

  • 21. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
    Katz MS
    Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins effect on smooth muscle cell proliferation.
    Bellosta S; Arnaboldi L; Gerosa L; Canavesi M; Parente R; Baetta R; Paoletti R; Corsini A
    Semin Vasc Med; 2004 Nov; 4(4):347-56. PubMed ID: 15861311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How do statins control neuroinflammation?
    Adamson P; Greenwood J
    Inflamm Res; 2003 Oct; 52(10):399-403. PubMed ID: 14520514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The non-lipid effects of statins].
    Paragh G; Márk L; Katona E
    Orv Hetil; 2004 Sep; 145(37):1903-10. PubMed ID: 15493621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins and cardiac allograft vasculopathy after heart transplantation.
    Kobashigawa JA
    Semin Vasc Med; 2004 Nov; 4(4):401-6. PubMed ID: 15861321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
    Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential vascular benefits of statins.
    Kinlay S
    Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plaque passivation: role of statins in acute coronary syndromes.
    Singh S; Bahl VK
    Indian Heart J; 2003; 55(6):605-10. PubMed ID: 14989509
    [No Abstract]   [Full Text] [Related]  

  • 30. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
    Ito MK; Talbert RL; Tsimikas S
    Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.
    Tristano AG; Fuller K
    Int Immunopharmacol; 2006 Dec; 6(12):1833-46. PubMed ID: 17052674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigations of statins in heart failure: inflammatory biomarkers and hormones.
    Khan BV; Rajagopalan S
    Heart Fail Clin; 2008 Apr; 4(2):171-6. PubMed ID: 18433697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Statins and asthma].
    Pawlak J; Ziętkowski Z; Bodzenta-Łukaszyk A
    Postepy Hig Med Dosw (Online); 2011 Mar; 65():177-89. PubMed ID: 21502694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation?
    Neal DA; Alexander GJ
    Liver Transpl; 2001 Dec; 7(12):1009-14. PubMed ID: 11753902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?
    Steffens S; Mach F
    Nat Clin Pract Nephrol; 2006 Jul; 2(7):378-87. PubMed ID: 16932466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
    Young RP; Hopkins R; Eaton TE
    Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory properties of statins.
    Steffens S; Mach F
    Semin Vasc Med; 2004 Nov; 4(4):417-22. PubMed ID: 15861323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins in dermatology.
    Jowkar F; Namazi MR
    Int J Dermatol; 2010 Nov; 49(11):1235-43. PubMed ID: 20964647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of HMG-CoA reductase inhibition on brain pathology.
    Zipp F; Waiczies S; Aktas O; Neuhaus O; Hemmer B; Schraven B; Nitsch R; Hartung HP
    Trends Pharmacol Sci; 2007 Jul; 28(7):342-9. PubMed ID: 17573124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
    Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
    Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.